Download Docs
Export
Print

DBITE

97341385 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed March 31, 2022
Serial No. 97341385
Examining Attorney null
Class Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergies, autoimmunity, inflammation, osteoporosis, graft versus host diseases, transplant rejection, cardiovascular diseases, metabolic diseases, neurological diseases, and minimal residual diseases; 005; 006; 018; 044; 046; 051; 052; 021; 023; 026; 036; 038; 002; 005; 022; 023; 029; 037; 038; 050; 100; 101; 102; 100; 101
DBITE
Case Type Trademark Service mark
Status Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Last Updated: 4 days, 14 hours ago
Filing Date # Docket Text